Noacid (Pantoprazole Sodium Sesquihydrate)

Pantoprazole Sodium Sesquihydrate, the active ingredient in Noacid, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid secretion and is used to treat acid‑related disorders such as GERD, erosive esophagitis, Zollinger‑Ellison syndrome, and to prevent NSAID‑induced ulcers.

GNH USA supplies Noacid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is indicated for several acid‑related conditions, acting on the gastric proton pump to lower acid output. - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of esophageal irritation. - Erosive esophagitis: facilitates mucosal healing and reduces recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors. - Prevention of NSAID‑induced gastric ulcers: lowers ulcer risk in patients requiring long‑term NSAID therapy.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually transient. - Nausea: occasional mild upset. - Abdominal pain: dull or cramping discomfort. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea. - Low magnesium levels: muscle cramps, irregular heartbeat. - Liver enzyme elevation: abnormal liver function tests. - Bone fracture risk: long‑term use may affect bone density. - Acute interstitial nephritis: kidney inflammation presenting with fever and rash.

When prescribing Pantoprazole, consider the following precautions. - Assess renal function: adjust use in severe impairment. - Monitor magnesium: especially with prolonged therapy. - Evaluate liver status: use cautiously in hepatic disease. - Review concomitant medications: potential for drug interactions. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.

Pantoprazole may interact with several drug classes, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Antiretrovirals (e.g., atazanavir, nelfinavir): may lower antiviral levels. - Antifungals (e.g., ketoconazole, itraconazole): reduced absorption and effectiveness.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, monitor coagulation. - Methotrexate: higher serum concentrations, watch for toxicity. - Digoxin: may increase serum levels, check cardiac status. - Clopidogrel: reduced antiplatelet effect, consider alternative therapy. - Iron supplements: decreased iron absorption, separate dosing by at least 2 hours.